159 related articles for article (PubMed ID: 36186772)
1. Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement.
Quattri E; Zussino M; Lauro W; Berti E; Marzano AV; Genovese G
Front Med (Lausanne); 2022; 9():1000954. PubMed ID: 36186772
[TBL] [Abstract][Full Text] [Related]
2. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract][Full Text] [Related]
3. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
[TBL] [Abstract][Full Text] [Related]
4. Cicatricial pemphigoid vegetans.
Woźniak K; Górkiewicz A; Olszewska M; Schwartz RA; Kowalewski C
Int J Dermatol; 2007 Mar; 46(3):299-302. PubMed ID: 17343590
[TBL] [Abstract][Full Text] [Related]
5. Urticarial Lesions in a Pregnant Woman.
Santos-Alarcón S; Benavente-Villegas C; García-Briz I; Moneva-Léniz M; Sanchis-Sánchez C; Mateu-Puchades A
Acta Dermatovenerol Croat; 2018 Apr; 26(1):71-72. PubMed ID: 29782306
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.
Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X
Front Immunol; 2022; 13():903174. PubMed ID: 35720393
[TBL] [Abstract][Full Text] [Related]
7. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
[TBL] [Abstract][Full Text] [Related]
8. A Case of IgG and IgA Anti-Laminin-332 Antibody-Positive Mucous Membrane Pemphigoid with IgG and IgA Anti-Envoplakin and Anti-Periplakin Antibodies.
Matsushima Y; Kitano M; Hayashi D; Goto H; Mine M; Yokoe T; Kondo M; Habe K; Toiyama Y; Hashimoto T; Tsuruta D; Takeuchi K; Yamanaka K
Dermatopathology (Basel); 2022 Aug; 9(3):287-291. PubMed ID: 35997351
[TBL] [Abstract][Full Text] [Related]
9. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
[TBL] [Abstract][Full Text] [Related]
10. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
11. Anti-BP180-type mucous membrane pemphigoid: report of two cases.
Wada M; Sato J; Shindoh M; Ujiie H; Natsuga K; Nishie W; Shimizu H; Kitagawa Y
Odontology; 2016 Jan; 104(1):114-8. PubMed ID: 25355555
[TBL] [Abstract][Full Text] [Related]
12. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.
Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH
Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979
[TBL] [Abstract][Full Text] [Related]
13. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
14. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
15. A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.
Nakatani K; Noborio R; Nomura Y; Ueki Y; Kiyohara T; Hashimoto T
J Dermatol; 2024 Jan; ():. PubMed ID: 38214494
[TBL] [Abstract][Full Text] [Related]
16. [Anti-laminin 5 mucous membrane pemphigoid].
Benoit S; Schmidt E; Sitaru C; Rose C; Goebeler M; Bröcker EB; Zillikens D
J Dtsch Dermatol Ges; 2006 Jan; 4(1):41-4. PubMed ID: 16503930
[TBL] [Abstract][Full Text] [Related]
17. The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases.
Qian H; Natsuaki Y; Koga H; Kawakami T; Tateishi C; Tsuruta D; Ishii N; Li X; Hashimoto T
Front Immunol; 2021; 12():771766. PubMed ID: 34899722
[TBL] [Abstract][Full Text] [Related]
18. [Mucous membrane pemphigoid].
Holtsche MM; Zillikens D; Schmidt E
Hautarzt; 2018 Jan; 69(1):67-83. PubMed ID: 29242962
[TBL] [Abstract][Full Text] [Related]
19. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
20. [Cicatricial pemphigoid with autoantibodies to laminin 5 (epiligrin) in a patient with metastatic endometrial carcinoma].
Lenz P; Hsu R; Yee C; Yancey K; Volc-Platzer B; Stingl G; Kirnbauer R
Hautarzt; 1998 Jan; 49(1):31-5. PubMed ID: 9522190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
